FDC Limited Stock price

Equities

FDC

INE258B01022

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:52 2024-03-28 am EDT 5-day change 1st Jan Change
424.6 INR +1.06% Intraday chart for FDC Limited -2.66% +7.20%
Sales 2022 15.28B 183M Sales 2023 17.84B 214M Capitalization 42.56B 511M
Net income 2022 2.16B 25.97M Net income 2023 1.94B 23.28M EV / Sales 2022 2.51 x
Net cash position 2022 5.06B 60.76M Net cash position 2023 4.53B 54.35M EV / Sales 2023 2.13 x
P/E ratio 2022
20 x
P/E ratio 2023
22 x
Employees 6,372
Yield 2022 *
-
Yield 2023
-
Free-Float 30.12%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.06%
1 week-2.66%
Current month-2.68%
1 month-4.50%
3 months+7.89%
6 months+9.25%
Current year+7.20%
More quotes
1 week
416.70
Extreme 416.7
434.55
1 month
405.75
Extreme 405.75
465.45
Current year
392.45
Extreme 392.45
487.50
1 year
254.75
Extreme 254.75
487.50
3 years
229.15
Extreme 229.15
487.50
5 years
152.00
Extreme 152
487.50
10 years
115.50
Extreme 115.5
487.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 88 67-04-20
Chief Executive Officer 61 93-09-29
Director of Finance/CFO - 23-04-05
Members of the board TitleAgeSince
Chief Executive Officer 61 93-09-29
Director/Board Member - 99-12-31
Director/Board Member 82 87-03-30
More insiders
Date Price Change Volume
24-03-28 424.6 +1.06% 30,638
24-03-27 420.1 -0.30% 11,070
24-03-26 421.4 -2.03% 7,862
24-03-22 430.1 -1.39% 6,512
24-03-21 436.2 +0.23% 5,486

Delayed Quote Bombay S.E., March 28, 2024 at 06:00 am EDT

More quotes
FDC Limited is an India-based company, which is principally engaged in the business of pharmaceuticals. The Company manufactures and distributes its range of generics, formulations, and active pharmaceuticals at its manufacturing plants. It also manufactures oral rehydration salts (ORS) and specialized formulations. It has a range of functional foods and beverages. Its active pharmaceutical ingredients (APIs) include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, among others. It has its presence in various therapeutic segments, such as anti-infectives, gastrointestinal, ophthalmological, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock FDC Limited - Bombay S.E.